{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:24:26Z","timestamp":1791138266674,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.hoc.2009.03.011","type":"journal-article","created":{"date-parts":[[2009,5,22]],"date-time":"2009-05-22T07:20:19Z","timestamp":1242976819000},"page":"415-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Melanoma Genetics: An Update on Risk-Associated Genes"],"prefix":"10.1016","volume":"23","author":[{"given":"Durga","family":"Udayakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hensin","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2009.03.011_bib1","series-title":"Cutaneous melanoma","first-page":"1","article-title":"A history of melanoma: from hunter to clark","author":"McLead","year":"2003"},{"key":"10.1016\/j.hoc.2009.03.011_bib2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archderm.1978.01640170032006","article-title":"Origin of familial malignant melanomas from heritable melanocytic lesions. \u2018The B-K mole syndrome\u2019","volume":"114","author":"Clark","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jmg.15.5.352","article-title":"Familial atypical multiple mole-melanoma syndrome","volume":"15","author":"Lynch","year":"1978","journal-title":"J Med Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.12968\/hmed.2006.67.6.21288","article-title":"The genetics of melanoma","volume":"67","author":"Bishop","year":"2006","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.hoc.2009.03.011_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/14737140.6.5.657","article-title":"High- and low-penetrance cutaneous melanoma susceptibility genes","volume":"6","author":"Fargnoli","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.hoc.2009.03.011_bib8","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","article-title":"Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J\u00a0Cancer"},{"key":"10.1016\/j.hoc.2009.03.011_bib9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM198905253202102","article-title":"Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p","volume":"320","author":"Bale","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2009.03.011_bib10","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1126\/science.1439824","article-title":"Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22","volume":"258","author":"Cannon-Albright","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.hoc.2009.03.011_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2009.03.011_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/375506a0","article-title":"Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition","volume":"375","author":"Koh","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2009.03.011_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/375503a0","article-title":"Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16","volume":"375","author":"Lukas","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2009.03.011_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","article-title":"The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53","volume":"92","author":"Pomerantz","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.hoc.2009.03.011_bib15","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1073\/pnas.95.14.8292","article-title":"Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2","volume":"95","author":"Kamijo","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hoc.2009.03.011_bib16","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","article-title":"The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2","volume":"17","author":"Stott","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.hoc.2009.03.011_bib17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0092-8674(00)81401-4","article-title":"ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways","volume":"92","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.hoc.2009.03.011_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2133.2008.08682.x","article-title":"Genetics of melanoma predisposition","volume":"159","author":"Lin","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of the INK4a locus in tumor suppression and cell mortality","volume":"85","author":"Serrano","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.hoc.2009.03.011_bib20","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1101\/gad.11.21.2822","article-title":"Cooperative effects of INK4a and ras in melanoma susceptibility in vivo","volume":"11","author":"Chin","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.hoc.2009.03.011_bib21","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.hoc.2009.03.011_bib22","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1038\/sj.onc.1208678","article-title":"A mutation hotspot at the p14ARF splice site","volume":"24","author":"Harland","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.hoc.2009.03.011_bib23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/hmg\/11.11.1273","article-title":"Germline mutation of ARF in a melanoma kindred","volume":"11","author":"Hewitt","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/gcc.20177","article-title":"Intronic sequence variants of the CDKN2A gene in melanoma pedigrees","volume":"43","author":"Harland","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.hoc.2009.03.011_bib25","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/10.23.2679","article-title":"A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees","volume":"10","author":"Harland","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib27","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1055-9965.EPI-06-0270","article-title":"The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study","volume":"15","author":"Berwick","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.hoc.2009.03.011_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00008469-200402000-00010","article-title":"Estimating the relative risk of developing melanoma in INK4A carriers","volume":"13","author":"Berwick","year":"2004","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.hoc.2009.03.011_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.bjc.6601503","article-title":"Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma","volume":"90","author":"Soufir","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hoc.2009.03.011_bib30","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/cncr.10454","article-title":"Multiple primary melanoma revisited","volume":"94","author":"Blackwood","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2009.03.011_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/gcc.1183","article-title":"Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect","volume":"32","author":"Auroy","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.hoc.2009.03.011_bib32","first-page":"6864","article-title":"CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas","volume":"60","author":"Hashemi","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.hoc.2009.03.011_bib33","first-page":"490","article-title":"CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia","volume":"36","author":"Ruiz","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1523-1747.1998.00267.x","article-title":"CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas","volume":"111","author":"MacKie","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199803263381305","article-title":"CDKN2A mutations in multiple primary melanomas","volume":"338","author":"Monzon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2009.03.011_bib36","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199510123331504","article-title":"Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations","volume":"333","author":"Goldstein","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2009.03.011_bib37","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archderm.136.9.1118","article-title":"Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma","volume":"136","author":"Tsao","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.cmr.0000131014.79262.bf","article-title":"Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma","volume":"14","author":"Berg","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1016\/j.hoc.2009.03.011_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/CEJ.0b013e3282f75eb1","article-title":"Low prevalence of CDKN2A\/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland","volume":"17","author":"Debniak","year":"2008","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.hoc.2009.03.011_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.jid.5700078","article-title":"Germline CDKN2A mutations among Greek patients with early-onset and multiple primary cutaneous melanoma","volume":"126","author":"Stratigos","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/jmg.2005.032441","article-title":"MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability","volume":"43","author":"Niendorf","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":"Geographical variation in the penetrance of CDKN2A mutations for melanoma","volume":"94","author":"Bishop","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2009.03.011_bib43","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/jnci\/dji312","article-title":"Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample","volume":"97","author":"Begg","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2009.03.011_bib44","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaad.2004.04.045","article-title":"Genetic testing in hereditary melanoma","volume":"51","author":"Tsao","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/cncr.11116","article-title":"A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors","volume":"97","author":"Goggins","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2009.03.011_bib46","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0016-5107(02)70092-8","article-title":"Screening and surveillance for hereditary pancreatic cancer","volume":"56","author":"Kimmey","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.hoc.2009.03.011_bib47","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.139.8.1019","article-title":"Pancreatic carcinoma surveillance in patients with familial melanoma","volume":"139","author":"Parker","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0595-114","article-title":"Mutations associated with familial melanoma impair p16INK4 function","volume":"10","author":"Ranade","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib49","first-page":"1173","article-title":"p16 proteins from melanoma-prone families are deficient in binding to Cdk4","volume":"11","author":"Reymond","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.hoc.2009.03.011_bib50","first-page":"109","article-title":"Novel mutations in the p16\/CDKN2A binding region of the cyclin-dependent kinase-4 gene","volume":"58","author":"Tsao","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.hoc.2009.03.011_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","article-title":"Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group","volume":"7","author":"Soufir","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib52","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jnci\/92.12.1006","article-title":"Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations","volume":"92","author":"Goldstein","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2009.03.011_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mrfmmm.2004.09.014","article-title":"MC1R and the response of melanocytes to ultraviolet radiation","volume":"571","author":"Rouzaud","year":"2005","journal-title":"Mutat Res"},{"key":"10.1016\/j.hoc.2009.03.011_bib54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0749.2005.00278.x","article-title":"Melanocortin-1 receptor structure and functional regulation","volume":"18","author":"Garcia-Borron","year":"2005","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.hoc.2009.03.011_bib55","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1034\/j.1600-0749.2003.00073.x","article-title":"Rate limiting factors in melanocortin 1\u00a0receptor signalling through the cAMP pathway","volume":"16","author":"Mas","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.hoc.2009.03.011_bib56","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","article-title":"Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans","volume":"11","author":"Valverde","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib57","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/ijc.23396","article-title":"MC1R variants, melanoma and red hair color phenotype: a meta-analysis","volume":"122","author":"Raimondi","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2009.03.011_bib58","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.0022-202x.2001.01421.x","article-title":"Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color","volume":"117","author":"Kennedy","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib59","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/323412","article-title":"MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations","volume":"69","author":"Box","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib60","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1055-9965.EPI-05-0321A","article-title":"Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations","volume":"14","author":"Goldstein","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.hoc.2009.03.011_bib61","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1126\/science.1127515","article-title":"MC1R germline variants confer risk for BRAF-mutant melanoma","volume":"313","author":"Landi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.hoc.2009.03.011_bib62","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/jid.2008.67","article-title":"MC1R variants increase risk of melanomas harboring BRAF mutations","volume":"128","author":"Fargnoli","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib63","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ng.160","article-title":"Two newly identified genetic determinants of pigmentation in Europeans","volume":"40","author":"Sulem","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib64","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.163","article-title":"Common sequence variants on 20q11.22 confer melanoma susceptibility","volume":"40","author":"Brown","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2009.03.011_bib65","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/sj.onc.1206445","article-title":"Genetics of melanoma predisposition","volume":"22","author":"Hayward","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.hoc.2009.03.011_bib66","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1600-0625.2006.00500.x","article-title":"Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients","volume":"15","author":"Lira","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib67","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/cncr.23867","article-title":"Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis","volume":"113","author":"Mocellin","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2009.03.011_bib68","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1200\/JCO.2005.05.054","article-title":"Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up","volume":"23","author":"Kleinerman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2009.03.011_bib69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.det.2007.08.011","article-title":"Genodermatoses with cutaneous tumors and internal malignancies","volume":"26","author":"Somoano","year":"2008","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.hoc.2009.03.011_bib70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clindermatol.2004.09.012","article-title":"Hereditary cancer syndromes of the skin","volume":"23","author":"Somoano","year":"2005","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.hoc.2009.03.011_bib71","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archderm.1994.01690080084012","article-title":"The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm","volume":"130","author":"Kraemer","year":"1994","journal-title":"Arch Dermatol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858809000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858809000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:53:11Z","timestamp":1760183591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858809000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0889858809000604"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2009.03.011","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma Genetics: An Update on Risk-Associated Genes","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2009.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}